Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15–29 Years in Norway
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To study long-term mortality, causes of death, and end-stage renal disease (ESRD) in people diagnosed with type 1 diabetes at age 15–29 years. RESEARCH DESIGN AND METHODS: This nationwide, population-based cohort with type 1 diabetes diagnosed during 1978–1982 (n = 719) was followed from diagnosis until death, emigration, or September 2013. Linkages to the Norwegian Cause of Death Registry and the Norwegian Renal Registry provided information on causes of death and whether ESRD was present. A clinical committee reviewed the causes of death. We calculated standardized mortality ratios (SMRs) for comparison with the background population. RESULTS: During 30 years’ follow-up, 4.6% of participants developed ESRD and 20.6% (n = 148; 106 men and 42 women) died. Cumulative mortality by years since diagnosis was 6.0% (95% CI 4.5–8.0) at 10 years, 12.2% (10.0–14.8) at 20 years, and 18.4% (15.8–21.5) at 30 years. The SMR was 4.4 (95% CI 3.7–5.1). Mean time from diagnosis of diabetes to ESRD was 23.6 years (range 14.2–33.5). Death was caused by chronic complications (32.2%), acute complications (20.5%), violent death (19.9%), or any other cause (27.4%). Death was related to alcohol in 15% of cases. SMR for alcohol-related death was 6.8 (95% CI 4.5–10.3), for cardiovascular death was 7.3 (5.4–10.0), and for violent death was 3.6 (2.3–5.3). CONCLUSIONS: The cumulative incidence of ESRD was low in this cohort with type 1 diabetes followed for 30 years. Mortality was 4.4 times that of the general population, and more than 50% of all deaths were caused by acute or chronic complications. A relatively high proportion of deaths were related to alcohol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study
Green, A., Gale, E. A. M., & Patterson, C. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)90938-y · Cited by 407 · cited 1×
“The cases were classified as type 1 diabetes according to EURODIAB criteria (18).”
MethodLong-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
Skrivarhaug, T., Bangstad, H.-J., Stene, L. C., Sandvik, L., Hanssen, K. F., & Joner, G. (2006) · Diabetologia · doi:10.1007/s00125-005-0082-6 · Cited by 390
Self-citationField, M., Wiers, R. W., Christiansen, P., Fillmore, M. T., & Verster, J. C. (2010) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01218.x · Cited by 282 · cited 1×
“Alcohol consumption impairs cognitive processes such as memory, attention, and planning, which are essential for people with type 1 diabetes (31).”
BackgroundPatterson, C. C., Dahlquist, G., Harjutsalo, V., Joner, G., Feltbower, R. G., Svensson, J., Schober, E., Gyürüs, E., Castell, C., Urbonaité, B., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0824-8 · Cited by 213
Self-citationMortality in type 1 diabetes in the DCCT/EDIC versus the general population
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-2399 · Cited by 194
Feltbower, R. G., Bodansky, H. J., Patterson, C. C., Parslow, R. C., Stephenson, C. R., Reynolds, C., & McKinney, P. A. (2008) · Diabetes Care · doi:10.2337/dc07-2029 · Cited by 183 · cited 2×
“A couple of mortality studies have shown abuse of drugs or alcohol among cohorts with type 1 diabetes, but neither provided long-term follow-up nor compared those cohorts with the general population (28,29).”
BackgroundAhmed, A. T., Karter, A. J., Warton, E. M., Doan, J. U., & Weisner, C. M. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0502-z · Cited by 132 · cited 1×
“It is also a marker for poorer adherence to diabetes self-management and glycemic control (32,33).”
BackgroundCauses of death in childhood‐onset Type 1 diabetes: long‐term follow‐up
Gagnum, V., Stene, L. C., Jenssen, T. G., Berteussen, L. M., Sandvik, L., Joner, G., Njølstad, P. R., & Skrivarhaug, T. (2017) · Diabetic Medicine · doi:10.1111/dme.13114 · Cited by 87
Self-citationLahti, R. A., Sajantila, A., Korpi, H., Poikolainen, K., & Vuori, E. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.05.029 · Cited by 27 · cited 1×
“It is known that alcohol consumption is underreported on death certificates (27).”
Background
Cited by
Lee, Y.-B., Han, K., Kim, B., Lee, S.-E., Jun, J. E., Ahn, J., Kim, G., Jin, S.-M., & Kim, J. H. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0953-7 · Cited by 131
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
Alcohol and illicit drug use in people with diabetes
Pastor, A., Conn, J., MacIsaac, R. J., & Bonomo, Y. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30410-3 · Cited by 53
Boggi, U., Baronti, W., Amorese, G., Pilotti, S., Occhipinti, M., Perrone, V., Marselli, L., Barsotti, M., Campani, D., Gianetti, E., et al. (2022) · Transplantation · doi:10.1097/tp.0000000000003627 · Cited by 25
Metadata
- Authors
- Gagnum, V., Stene, L. C., Leivestad, T., Joner, G., & Skrivarhaug, T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-10-21
- Volume
- 40
- Issue
- 1
- Pages
- 38-45
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2538561309
- Cited by
- 44
- References
- 10
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.